Urso Forte Alternatives Compared
Urso Forte (ursodiol) | Elafibranor | Seladelpar |
|
---|
Urso Forte (ursodiol) | Elafibranor | Seladelpar |
|
---|---|---|---|
Prescription only
Prescribed for Primary Biliary Cholangitis, Gallbladder Disease. Urso Forte may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Primary Biliary Cholangitis. Elafibranor may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Primary Biliary Cholangitis. Seladelpar may also be used for purposes not listed in this medication guide. |
|
More about Urso Forte (ursodiol) | More about Elafibranor | More about Seladelpar | |
Ratings & Reviews | |||
Urso Forte has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
|
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||
View all Urso Forte side effects |
View all Elafibranor side effects |
View all Seladelpar side effects |
|
Drug Class | |||
Generic Availability | |||
Lower cost generic approved |
N/A |
N/A |
|
Pricing and Coupons * Prices are without insurance | |||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
Dosage Forms | |||
|
N/A |
N/A |
|
Brand Names | |||
Other ursodiol brands include: Actigall, Reltone, Urso | Iqirvo | Livdelzi | |
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||
139.2 hours |
92.2 hours |
6 hours |
|
CSA Schedule 1 View glossary of CSA terms | |||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
Pregnancy Category | |||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. |
|
Drug Interactions | |||
A total of 7 drugs are known to interact with Urso Forte:
|
A total of 249 drugs are known to interact with Elafibranor:
|
A total of 150 drugs are known to interact with Seladelpar:
|
|
Alcohol/Food/Lifestyle Interactions | |||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
Disease Interactions | |||
First Approval Date | |||
December 10, 1997 |
June 10, 2024 |
August 14, 2024 |
|
WADA Class View classifications | |||
N/A |
N/A |
N/A |
|
More Information | |||
Patient Resources | |||
Professional Resources | |||
N/A |
|||
Related Treatment Guide | |||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.